Search - tctmd.com

Displaying 961 - 980 of 989

Sort: Relevancy | Date

News Daily News

Lean Body Mass Adds New Evidence to ‘Obesity Paradox’ in CAD Patients

L.A. McKeown

September 12, 2012

News Daily News

Indirect Comparisons Show Little Difference Among New Anticoagulants

August 14, 2012

News Daily News

Un Registro Revela una Mejor Supervivencia para las Mujeres que para los Hombres con la TAVR

Caitlin E. Cox

July 19, 2012

News Daily News

Registry Shows Better Survival for Women vs. Men After TAVR

Caitlin E. Cox

July 19, 2012

News Daily News

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

July 12, 2012

News Daily News

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

July 03, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

L.A. McKeown

March 24, 2012

News Daily News

African-Americans Have Higher Bleeding Rates After Reperfusion for STEMI

L.A. McKeown

March 20, 2012

News Daily News

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Caitlin E. Cox

March 12, 2012

News Daily News

Iodinated Contrast Agents Tied to Potential Thyroid Dysfunction

Yael L. Maxwell

January 30, 2012

News Daily News

Women Benefit From TAVR as Much as Men, Maybe More

Jason Kahn

January 29, 2012

News Daily News

Similar Mortality Rates Seen in Men and Women with NSTE ACS

L.A. McKeown

January 26, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Daily News

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Yael L. Maxwell

December 14, 2011

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

New-Generation DES Reduce Restenosis, Stent Thrombosis

August 29, 2011

News Conference News

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

August 28, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Conference News

Paclitaxel Balloon Maintains Advantage at 5 Years

Caitlin E. Cox

May 20, 2011

News Daily News

Predictors of Adverse Events in Pulmonary Artery Intervention Identified

L.A. McKeown

May 06, 2011

Advertisement

Lean Body Mass Adds New Evidence to ‘Obesity Paradox’ in CAD Patients

Indirect Comparisons Show Little Difference Among New Anticoagulants

Un Registro Revela una Mejor Supervivencia para las Mujeres que para los Hombres con la TAVR

Registry Shows Better Survival for Women vs. Men After TAVR

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

African-Americans Have Higher Bleeding Rates After Reperfusion for STEMI

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Iodinated Contrast Agents Tied to Potential Thyroid Dysfunction

Women Benefit From TAVR as Much as Men, Maybe More

Similar Mortality Rates Seen in Men and Women with NSTE ACS

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

New-Generation DES Reduce Restenosis, Stent Thrombosis

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

Women Have Less Neointimal Hyperplasia Than Men With ZES

Paclitaxel Balloon Maintains Advantage at 5 Years

Predictors of Adverse Events in Pulmonary Artery Intervention Identified

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content